{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T11:20:44Z","timestamp":1773660044803,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004728","name":"VIT University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004728","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.jim.2019.112637","type":"journal-article","created":{"date-parts":[[2019,8,3]],"date-time":"2019-08-03T10:03:00Z","timestamp":1564826580000},"page":"112637","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Development of anti-chloro 192 tyrosine HDL apoA-I antibodies for the immunodiagnosis of cardiovascular diseases"],"prefix":"10.1016","volume":"474","author":[{"given":"Kirubanandhan","family":"Lokeshwaran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrey","family":"Hemadou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.S.","family":"Jayaprakash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.R.","family":"Prasanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Jos\u00e9e","family":"Jacobin-Valat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilfrid","family":"Dieryck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilles","family":"Joucla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Vijayalakshmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gis\u00e8le","family":"Clofent-Sanchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Santarelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishnan","family":"Venkataraman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jim.2019.112637_bb0005","doi-asserted-by":"crossref","first-page":"7856","DOI":"10.1074\/jbc.M309046200","article-title":"Lysine residues direct the chlorination of tyrosines in YXXK motifs of apolipoprotein A-I when hypochlorous acid oxidizes high density lipoprotein","author":"Bergt","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"35","key":"10.1016\/j.jim.2019.112637_bb0010","doi-asserted-by":"crossref","first-page":"13032","DOI":"10.1073\/pnas.0405292101","article-title":"The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport","volume":"101","author":"Bergt","year":"2004","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jim.2019.112637_bb0015","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"issue":"1","key":"10.1016\/j.jim.2019.112637_bb0020","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1172\/JCI117342","article-title":"Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions","volume":"94","author":"Daugherty","year":"1994","journal-title":"J. Clin. Invest."},{"issue":"15","key":"10.1016\/j.jim.2019.112637_bb0025","doi-asserted-by":"crossref","first-page":"10276","DOI":"10.1074\/jbc.M114.556506","article-title":"Site-specific nitration of apolipoprotein A-I at tyrosine 166 is both abundant within human atherosclerotic plaque and dysfunctional","volume":"289","author":"DiDonato","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jim.2019.112637_bb0030","doi-asserted-by":"crossref","first-page":"C7","DOI":"10.1016\/j.jacc.2005.09.068","article-title":"Pathogenesis of atherosclerosis","volume":"47","author":"Falk","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jim.2019.112637_bb0035","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1023\/A:1008170226665","article-title":"New method for the selective capture of antibodies under physiological conditions","volume":"9","author":"Guerrier","year":"2000","journal-title":"Bioseparation"},{"issue":"3","key":"10.1016\/j.jim.2019.112637_bb0040","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/cvr\/cvu147","article-title":"HDL-mediated mechanisms of protection in cardiovascular disease","volume":"103","author":"Kontush","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.jim.2019.112637_bb0045","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural protein during the assembly of the head bacteriophage T4","volume":"22","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.jim.2019.112637_bb0050","doi-asserted-by":"crossref","first-page":"33S","DOI":"10.2967\/jnumed.109.069633","article-title":"The vascular biology of atherosclerosis and imaging targets","volume":"1","author":"Libby","year":"2010","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.jim.2019.112637_bb0055","first-page":"903","article-title":"Development of monoclonal antibody against chlorinated 192 tyrosine containing ApoA1 peptide to screen quality of human high density Lipoprotein (HDL)","volume":"23","author":"Lokeshwaran","year":"2016","journal-title":"J. Protein Peptide Lett."},{"key":"10.1016\/j.jim.2019.112637_bb0060","doi-asserted-by":"crossref","first-page":"42977","DOI":"10.1074\/jbc.M406762200","article-title":"Human atherosclerotic intima and blood of patients with established coronary artery disease contain high density lipoprotein damaged by reactive nitrogen species","volume":"279","author":"Pennathur","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jim.2019.112637_bb0065","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jchromb.2014.02.020","article-title":"Affinity selection of histidine containing peptides using metal chelate methacrylate monolithic disk for targeted LCMS\/MS approach in high- throughput proteomics","volume":"955-956","author":"Prasanna","year":"2014","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jim.2019.112637_bb0070","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jpba.2013.02.010","article-title":"Production and characterization of monoclonal antibodies (mAbs) against human serum albumin (HSA) for the development of an immunoaffinity system with oriented anti-HSA mAbs as immobilized ligand","volume":"78-79","author":"Rajak","year":"2013","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jim.2019.112637_bb0075","series-title":"Molecular Cloning: A Laboratory Manual","author":"Sambrook","year":"2001"},{"issue":"7","key":"10.1016\/j.jim.2019.112637_bb0080","doi-asserted-by":"crossref","first-page":"5983","DOI":"10.1074\/jbc.M411484200","article-title":"Tyrosine 192 in apolipoprotein A-I is the major site of nitration and chlorination by myeloperoxidase, but only chlorination markedly impairs ABCA1-dependent cholesterol transport","volume":"280","author":"Shao","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jim.2019.112637_bb0085","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1021\/tx9003775","article-title":"Myeloperoxidase: an oxidative pathway for generating dysfunctional high-density lipoprotein","volume":"23","author":"Shao","year":"2010","journal-title":"Chem. Res. Toxicol."},{"issue":"9","key":"10.1016\/j.jim.2019.112637_bb0090","doi-asserted-by":"crossref","first-page":"6375","DOI":"10.1074\/jbc.M111.337345","article-title":"Myeloperoxidase targets apolipoprotein A-I, the major high density lipoprotein protein for site-specific oxidation in human atherosclerotic lesions","volume":"287","author":"Shao","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jim.2019.112637_bb0095","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cca.2006.11.002","article-title":"Establishment and evaluation of 2 monoclonal antibodies against oxidized apolipoprotein A-I (apoA-I) and its application to determine blood oxidized apoA-I levels","volume":"378","author":"Ueda","year":"2007","journal-title":"Clin. Chim. Acta"},{"issue":"4","key":"10.1016\/j.jim.2019.112637_bb0100","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1172\/JCI200421109","article-title":"Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease","volume":"114","author":"Zheng","year":"2004","journal-title":"J. Clin. Invest."}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002217591930184X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002217591930184X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T16:38:10Z","timestamp":1758299890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002217591930184X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":20,"alternative-id":["S002217591930184X"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2019.112637","relation":{},"ISSN":["0022-1759"],"issn-type":[{"value":"0022-1759","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of anti-chloro 192 tyrosine HDL apoA-I antibodies for the immunodiagnosis of cardiovascular diseases","name":"articletitle","label":"Article Title"},{"value":"Journal of Immunological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jim.2019.112637","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112637"}}